who is developing retatrutide 🚨 JUST RELEASED TODAY!!!! NEW PHASE 3 DATA Today, July 23, 2026, new Phase 3 retatrutide results were released, adding to what already one of the most interesting obesity drug This weight-loss drug hasn't been

Using sterile water eliminates the bacterial inhibitor, making the solution unsafe for repeated draws

If you have concerns about medication detection for employment, insurance, or other purposes, discuss them openly with your healthcare provider

OSHI Health

NICE guidance on obesity pharmacotherapy is based on robust, peer-reviewed evidence from completed trial programmes, and retatrutide has not yet reached that threshold

'If you qualify for the actual medications, that would be the best route.' Read next: Energy drinks may boost cancer growth, according to new research here's why 3 simple food rules Mary Berry swears by to stay healthy at 90 Stop falling for these 4 viral gut health trends a nutritionist explains why Nutritionist Emily English's high-protein steak bowl recipe is perfect for summer lunches Cut through the noise and get practical, expert advice, home workouts, easy nutrition and more direct to your inbox

Moreover, the PCE of retatrutide was not reversed by ProGIP (Table 1)